ARTICLE | Clinical News
Corplex Donepezil Transdermal System: Phase I data
February 15, 2016 8:00 AM UTC
Top-line data from an open-label, crossover, Australian Phase I trial in 9 healthy volunteers ages 50-80 showed that the Corplex Donepezil Transdermal System targeted to deliver 5 mg/day of donepezil ...